Frontiers in Innovative Pharmaceutical Modalities

Frontiers in Innovative Pharmaceutical Modalities

Liquid error (snippets/article-card line 119): The format option '%d %b, %Y' is not a supported format.AntBio

  Industry Overview The innovative drug landscape has transitioned from traditional small molecules and monoclonal antibodies into an explosive paradigm of New Modalities: Antibody‑Drug Conjugates (ADCs), Bispecific/Multispecific Antibodies, Targeted Protein...

20 Aug 2026AntBio

Frontiers in Innovative Pharmaceutical Modalities

  Industry Overview The innovative drug landscape has transitioned from traditional small molecules and monoclonal antibodies into an explosive paradigm of New Modalities: Antibody‑Drug Conjugates (ADCs), Bispecific/Multispecific Antibodies, Targeted Protein...

Read More
Electrostatic Interactions Governing Initial Triggering Events Within T‑Cell Receptor Signalling Cascades

Electrostatic Interactions Governing Initial Triggering Events Within T‑Cell ...

Liquid error (snippets/article-card line 119): The format option '%d %b, %Y' is not a supported format.AntBio

This adaptive‑immunology review interprets electrostatic‑charge‑driven TCR‑signal‑initiation mechanisms, CD3ε basic‑rich‑sequence (BRS) membrane‑shielding, Lck unique‑domain substrate‑selectivity, antigen‑strength‑dependent ITAM‑phosphorylation patterns. It provides Phospho‑Src Family (Tyr416) recombinant rabbit mAb (S0B1068) from ANT BIO PTE....

20 Aug 2026AntBio

Electrostatic Interactions Governing Initial Triggering Events Within T‑Cell ...

This adaptive‑immunology review interprets electrostatic‑charge‑driven TCR‑signal‑initiation mechanisms, CD3ε basic‑rich‑sequence (BRS) membrane‑shielding, Lck unique‑domain substrate‑selectivity, antigen‑strength‑dependent ITAM‑phosphorylation patterns. It provides Phospho‑Src Family (Tyr416) recombinant rabbit mAb (S0B1068) from ANT BIO PTE....

Read More
RIPK1 Kinase Activity (Ser166): Regulatory Mechanisms and Biological Outputs Within TNFR1‑Mediated Signal Transduction

RIPK1 Kinase Activity (Ser166): Regulatory Mechanisms and Biological Outputs ...

Liquid error (snippets/article-card line 119): The format option '%d %b, %Y' is not a supported format.AntBio

This cell‑signalling review interprets TNFR1‑triggered complex‑I/complex‑II signalling cascades, multi‑layered RIPK1 post‑translational regulation (phosphorylation‑ubiquitination), Ser166 autophosphorylation as RIPK1‑kinase activation marker, apoptosis‑necroptosis cell‑fate decisions and RIPK1‑inhibitor pre‑clinical research. It presents Phospho‑RIP (Ser166)...

20 Aug 2026AntBio

RIPK1 Kinase Activity (Ser166): Regulatory Mechanisms and Biological Outputs ...

This cell‑signalling review interprets TNFR1‑triggered complex‑I/complex‑II signalling cascades, multi‑layered RIPK1 post‑translational regulation (phosphorylation‑ubiquitination), Ser166 autophosphorylation as RIPK1‑kinase activation marker, apoptosis‑necroptosis cell‑fate decisions and RIPK1‑inhibitor pre‑clinical research. It presents Phospho‑RIP (Ser166)...

Read More
Selective Degradation of Phosphorylated p38 MAPK (Tyr182): Novel Mechanistic Insights for Alzheimer‑Disease‑Oriented Basic‑Research

Selective Degradation of Phosphorylated p38 MAPK (Tyr182): Novel Mechanistic ...

Liquid error (snippets/article-card line 119): The format option '%d %b, %Y' is not a supported format.AntBio

This neurodegeneration‑biology review interprets pathological roles of dually‑phosphorylated p38 MAPK (Thr180/Tyr182) in Alzheimer‑disease‑related neuroinflammation, limitations of conventional ATP‑competitive kinase inhibitors, conformation‑selective PROTAC PRZ‑18002 mechanism and 5xFAD mouse in‑vivo experimental outcomes....

20 Aug 2026AntBio

Selective Degradation of Phosphorylated p38 MAPK (Tyr182): Novel Mechanistic ...

This neurodegeneration‑biology review interprets pathological roles of dually‑phosphorylated p38 MAPK (Thr180/Tyr182) in Alzheimer‑disease‑related neuroinflammation, limitations of conventional ATP‑competitive kinase inhibitors, conformation‑selective PROTAC PRZ‑18002 mechanism and 5xFAD mouse in‑vivo experimental outcomes....

Read More
mTOR (Ser2448) Phosphorylation: Decoding Central Regulatory Nodes Within mTOR‑Mediated Signalling Networks

mTOR (Ser2448) Phosphorylation: Decoding Central Regulatory Nodes Within mTOR...

Liquid error (snippets/article-card line 119): The format option '%d %b, %Y' is not a supported format.AntBio

This cell‑metabolism signalling review explains mTORC1‑mTORC2 complex structural‑functional divergence, Ser2448 phosphorylation as mTORC1 activity read‑out, PI3K‑Akt‑AMPK upstream control and S6K1‑IRS1 negative‑feedback circuits. It features Phospho‑mTOR (Ser2448) recombinant rabbit mAb (S0B0597)...

20 Aug 2026AntBio

mTOR (Ser2448) Phosphorylation: Decoding Central Regulatory Nodes Within mTOR...

This cell‑metabolism signalling review explains mTORC1‑mTORC2 complex structural‑functional divergence, Ser2448 phosphorylation as mTORC1 activity read‑out, PI3K‑Akt‑AMPK upstream control and S6K1‑IRS1 negative‑feedback circuits. It features Phospho‑mTOR (Ser2448) recombinant rabbit mAb (S0B0597)...

Read More
LATS1/2 Kinase (Ser909/872): Dual‑Function Regulator Balancing Intestinal Stem‑Cell Fate and Wnt‑Pathway Output

LATS1/2 Kinase (Ser909/872): Dual‑Function Regulator Balancing Intestinal Ste...

Liquid error (snippets/article-card line 119): The format option '%d %b, %Y' is not a supported format.AntBio

This stem‑cell‑signalling review interprets dual‑mode regulatory functions of Hippo‑LATS1/2 kinase (Ser909/Ser872 phosphorylation) in intestinal‑stem‑cell homeostasis, YAP‑TAZ‑TLE‑TCF Wnt‑suppression, TEAD‑driven crypt‑proliferation, and Apc‑mutant intestinal tumour pre‑clinical‑model findings. It presents Phospho‑LATS1/2 (Ser909/872) recombinant...

20 Aug 2026AntBio

LATS1/2 Kinase (Ser909/872): Dual‑Function Regulator Balancing Intestinal Ste...

This stem‑cell‑signalling review interprets dual‑mode regulatory functions of Hippo‑LATS1/2 kinase (Ser909/Ser872 phosphorylation) in intestinal‑stem‑cell homeostasis, YAP‑TAZ‑TLE‑TCF Wnt‑suppression, TEAD‑driven crypt‑proliferation, and Apc‑mutant intestinal tumour pre‑clinical‑model findings. It presents Phospho‑LATS1/2 (Ser909/872) recombinant...

Read More